Andurand Says Oil Must Hit $110 Before Saudi Arabia Eases Supply Curbs - Yahoo Finance

Andurand Says Oil Must Hit $110 Before Saudi Arabia Eases Supply Curbs

(Bloomberg) -- Oil trader Pierre Andurand said he expects Saudi Arabia to keep its current supply curbs in place until prices reach at least $110 a barrel.

Most Read from Bloomberg

Israel Latest: Biden Says Gaza Aid Is Slow, Blinken Backs Pauses
An Oil Giant Quietly Ditched the World’s Biggest Carbon Capture Plant
Nobody Wants Mutual Funds Now
Xi Makes Unprecedented Central Bank Visit in Sign of Focus on Economy
Jamie Dimon Criticizes Central Banks for Getting Forecasts Wrong

As inventories decline in the coming months, “the market will have to beg for more supply at some point,” the founder of Andurand Capital Management LLP said during a question-and-answer session at Saudi Arabia’s Future Investment Initiative in Riyadh.

“The Saudis will have to decide when and at what price to bring supply back,” he added. “For me, an adjustment likely will come around $110 a barrel. So there’s room to the upside for prices.”

Since July, Saudi Arabia has pledged to implement a unilateral production cut of 1 million barrels a day on top of existing curbs. The kingdom earlier this month said it would keep the curbs in place until the end of the year.

Andurand said Saudi policy remains the deciding factor for crude prices. Global benchmark Brent oil is back below $90, even as the Israel-Hamas war threatens greater conflict in the Middle East. It’s “not impossible” that there will be direct confrontation with Iran that may change the landscape, he said.

Andurand sees oil demand reaching a high later this decade, then trailing off. On the topic of metals, he warned of trouble for copper markets, as mining supply is expected to peak while demand accelerates due to the energy transition.

Most Read from Bloomberg Businessweek

Lululemon’s Founder Is Racing to Cure the Rare Disease Destroying His Muscles
Inflation Raging at 130% Is Pushing Argentina Down a Radical Path
The Price of Money Is Going Up, and It’s Not Because of the Fed
The Ozempic Effect Is Coming for Everything From Kidney to Heart Disease Treatments
UBS Looks Beyond Credit Suisse to Bank Even More Billionaires

©2023 Bloomberg L.P.